LYON, France, June 14, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the approval of its Sonolith® i-move lithotripter by the Japanese Health Authorities allowing for the marketing of EDAP’s innovative Sonolith i-move lithotripter in the Japanese territory. EDAP also announced today the approval of its Sonolith® i-sys high-end integrated lithotripter in Taiwan.
